Selecting the Best Prostate Cancer Centres and Hospitals in India — A Congolese Patient's Guide

Author:- Dr. Dheeraj Bojwani Date Created:- 24-08-2026

Choosing a prostate cancer centre means finding both a skilled, experienced urologist and a genuine multidisciplinary team capable of weighing surgery, radiotherapy, and hormone therapy honestly against each other. In 24 years of guiding patients through this exact decision, I have found that given how much more aggressively this disease tends to behave in men of African ancestry, verifying that a centre understands and treats for this reality, rather than defaulting to standard assumptions, matters more here than it might elsewhere. This guide sets out, plainly, how a Congolese patient should judge both.

Healing Journeys of Congolese Patients

Congolese Patients Share Their Experience

Key Takeaways

• The guide stresses that complete staging must come before choosing treatment. PSA, imaging and biopsy grading should establish the cancer's stage and risk group so that treatment is based on the patient's actual disease rather than a standard assumption.
• The page 1 graphic gives 48% weighting to the surgeon/urologist and 52% to the multidisciplinary team, showing that both individual expertise and coordinated care are important, with a slight advantage to the team.
• The guide recommends a named urologist or surgical oncologist with genuine prostate cancer case volume, experience with the patient's exact stage and risk group, and an honest comparison of surgery, radiotherapy and combined treatment.
• The page 3 chart ranks named specialist case volume and a genuine multidisciplinary tumour board highest, followed by complete staging, honest treatment comparison and experience with the patient's specific risk group. It also highlights continence and sexual-function counselling.
• The guide warns that headline treatment costs may exclude hormone therapy or radiotherapy, particularly when combined treatment is required for higher-risk disease. Patients should obtain a complete itemised quotation before paying any deposit.
• For Congolese patients, the guide recommends sending actual PSA, imaging and biopsy results, confirming experience with aggressive or earlier-onset cases, keeping a 15–20% financial margin, and arranging medical and attendant visas plus a current yellow-fever certificate before travel.

Quick Facts

Author

Dr. Dheeraj Bojwani

Experience

24+ Years

Treatment

Prostate Cancer Treatment

Patients

Congolese Patients

First Assessment

PSA, imaging and biopsy grading

Key Specialist

Urologist / Surgical Oncologist

Decision Weighting

Surgeon 48% / Multidisciplinary Team 52%

Team Check

Genuine multidisciplinary tumour board

Risk Assessment

Exact stage and risk group

Treatment Options

Surgery, radiotherapy or combined treatment

Support

Continence and sexual-function counselling

Cost Check

Written, itemised complete treatment estimate

Financial Buffer

15–20%

Medical Records

PSA, imaging and biopsy results

Visa

Medical and attendant visa

Entry Requirement

Current yellow-fever certificate

Follow-Up

DRC follow-up plan

Key Warning

Avoid treatment based on incomplete staging

Decision Principle

Choose honest multidisciplinary assessment alongside specialist prostate cancer experience.

In Brief

For Congolese patients seeking prostate cancer treatment in India, the guide recommends complete staging, an experienced urologist and a genuine multidisciplinary tumour board. Treatment should be selected after honestly comparing surgery, radiotherapy and combined approaches according to the patient's stage and risk group.

First, Insist on Complete Staging Before Any Plan

Before comparing centres, make sure your evaluation includes full staging: PSA levels, imaging, and a biopsy with a clear grading of how aggressive the cancer appears. These results should determine your treatment plan — not a default assumption about what "typical" prostate cancer looks like.

This distinction matters because a treatment plan built on incomplete staging risks under-treating a case that is, statistically, more likely to be aggressive than the average case a Western-trained team might expect. A centre with genuine experience treating men of African ancestry will already understand this and stage accordingly, rather than applying a one-size-fits-all approach.

Two Decisions, Weighed

Choosing well depends on two things: the urologist's or surgeon's own experience, and the hospital's genuine multidisciplinary team. The two are close to evenly weighted for prostate cancer, with the team's completeness carrying slightly more weight, because so much of the decision between surgery, radiotherapy, and combined therapy depends on a coordinated, honest assessment rather than one specialist's default approach.

Part One: Choosing the Surgeon or Urologist

These three points matter more than a hospital's overall reputation or general marketing claims.

1. A named urologist or surgical oncologist with genuine case volume — ask directly how many prostate cancer cases they treat in a typical year.
2. Experience with your exact stage and risk group, since low-risk, intermediate-risk, and high-risk prostate cancer call for genuinely different approaches.
3. An honest surgery-versus-radiotherapy-versus-combined assessment, explaining clearly why one approach suits your specific case better than another.

A urologist's overall surgical volume does not automatically indicate deep, specific experience with more aggressive or earlier-onset prostate cancer. Ask directly what proportion of their caseload involves higher-risk disease, since this is the pattern many Congolese patients will actually present with.

Part Two: Verifying the Multidisciplinary Team

This is the part most families cannot judge from a brochure alone, which is exactly why it needs direct, specific questions rather than general reassurance.

4. A genuine multidisciplinary tumour board, where urology, medical oncology, and radiation oncology specialists review your case together.
5. Full staging before any treatment plan, including PSA, imaging, and biopsy grading, confirmed and reviewed as a complete picture.
6. Nerve-sparing technique discussed clearly, if surgery is recommended and relevant to your case.
7. Continence and sexual function counselling offered upfront, not left until after treatment decisions are already made.
8. NABH accreditation in India, or JCI internationally, auditing patient safety and clinical governance in depth.

What the quote doesn't always show

In 24 years of reviewing these estimates, I have found the disputes almost never concern the headline number — they concern what it silently left out: hormone therapy quoted separately and disclosed only once surgery is already scheduled, or radiotherapy priced apart from the rest of the treatment. Get every line item in writing before paying any deposit, and never pay the full balance before treatment.

Since combined treatment involving surgery, radiotherapy, or hormone therapy together is common for higher-risk disease, it is worth confirming upfront whether the quote reflects the complete pathway your specific case is likely to need, rather than only the first step.

What a Congolese Patient Should Weigh in Particular

Send your actual PSA, imaging, and biopsy results, not just a description of your diagnosis, to every centre being compared.

Ask directly whether the team has specific experience with more aggressive, earlier-onset presentations, given the documented pattern in men of African ancestry.

Currency and budget. The Congolese franc has weakened considerably against the dollar (roughly CDF 2,300–2,350 per US$1 in mid-2026, and it moves); budget with a 15–20% margin above the written estimate.

Visa timing. DRC passport holders need a paper medical visa through the Embassy of India in Kinshasa (Avenue Batetela, Gombe), typically around two weeks once the hospital's invitation letter is ready; apply for the attendant visa in the same batch.

Yellow fever certificate, current and dated at least 10 days before travel.

Four signals that should make you pause

• No multidisciplinary tumour board, only a single specialist making decisions independently.
• No genuine PSA, imaging, or biopsy grading behind the treatment plan.
• No discussion of continence or sexual function before treatment decisions are made.
• Pressure to pay the full balance before a written, complete treatment plan exists.

Weigh these signals together rather than dismissing any one alone, and pay particular attention to the first two, since a treatment plan built on incomplete staging or without a genuine team review carries real risk regardless of how confident the recommendation sounds.

A closing word

Prostate cancer treatment succeeds as much on a genuinely honest, complete assessment as on the surgeon's individual skill, and this matters even more given how much more aggressively this disease often behaves in men of African ancestry. A named, experienced urologist backed by a genuine multidisciplinary tumour board is the baseline worth insisting on before any deposit is paid, and no confident, well-established centre will hesitate to demonstrate this clearly. If you can share your PSA, imaging, and biopsy results, I am glad to review them honestly, including telling you if a proposed centre's team does not look sufficiently complete for your specific case.

Sources

• 🌐 National Medical Commission of India — verify any surgeon's registration · nmc.org.in
• 🌐 National Accreditation Board for Hospitals & Healthcare Providers (NABH) · nabh.co
• 🌐 Embassy of India, Kinshasa — medical visa requirements · eoikinshasa.gov.in
• 🌐 "Prostate cancer genetic risk and associated aggressive disease in men of African ancestry," Nature Communications · nature.com
• 🌐 World Health Organization — yellow fever vaccination requirements · who.int/health-topics/yellow-fever

Frequently Asked Questions by Congolese Patients about Selecting the Best Prostate Cancer Centres and Hospitals in India

What tests are needed before treatment?

The guide recommends PSA, imaging and biopsy grading to establish the cancer's stage and risk group.

How should patients choose a urologist?

Ask about the specialist's annual prostate cancer case volume and experience with the patient's specific stage and risk group.

Should surgery always be chosen?

No. The guide recommends an honest comparison of surgery, radiotherapy and combined treatment for the individual case.

Why is a tumour board important?

A multidisciplinary tumour board allows urology, medical oncology and radiation oncology specialists to review the case together.

What support should be discussed before treatment?

Patients should receive counselling about continence and sexual function, particularly when surgery is being considered.

Why can the treatment cost change?

Higher-risk disease may require combined treatment involving surgery, radiotherapy or hormone therapy, which may not be included in an initial quotation.

What records should Congolese patients send?

Send the actual PSA, imaging and biopsy results to each centre being compared.

How much financial buffer is recommended?

The guide recommends keeping a 15–20% margin above the written estimate.

What travel documents are highlighted?

The guide highlights paper medical and attendant visas and a current yellow-fever certificate dated at least 10 days before travel.

What are the main warning signs?

Be cautious if there is no multidisciplinary tumour board, incomplete staging, no discussion of continence or sexual function, or pressure to pay the full balance before a complete written plan.

Page Summary

This five-page guide focuses on complete staging, specialist experience and multidisciplinary treatment assessment. The page 1 graphic gives 52% weighting to the multidisciplinary team, while page 3 places specialist case volume and tumour-board review at the top. Page 4 highlights complete treatment costing, travel preparation and warning signs.

Citation Block

Field	Information
Topic	Prostate Cancer Treatment in India for Congolese Patients
Treatment	Prostate Cancer Treatment
Patients	Congolese Patients
First Assessment	PSA, imaging and biopsy grading
Key Specialist	Urologist / Surgical Oncologist
Decision Weighting	Surgeon 48% / Team 52%
Team Check	Multidisciplinary tumour board
Risk Assessment	Exact stage and risk group
Treatment Choice	Surgery vs radiotherapy vs combined
Specialist Experience	Prostate cancer case volume
Exact Case Experience	Experience with the patient's stage and risk group
Support	Continence and sexual-function counselling
Cost Check	Complete written estimate
Financial Buffer	15–20%
Medical Records	PSA, imaging and biopsy results
Visa	Medical and attendant visa
Follow-Up	DRC follow-up plan
Warning Signs	Incomplete staging, no tumour board or early full-payment pressure
Key Questions	Treatment sequence, specialist experience and expected outcomes
Key Decision	Prioritise complete assessment and specialist experience